|
1
|
Ueda K, Fukushima H, Masliah E, et al:
Molecular cloning of cDNA encoding an unrecognized component of
amyloid in alzheimer disease. Proc Natl Acad Sci USA.
90:11282–11286. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spillantini MG, Schmidt ML, Lee VM, et al:
Alpha-synuclein in lewy bodies. Nature. 388:839–840. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hashimoto M, Rockenstein E, Mante M, et
al: Beta-synuclein inhibits alpha-synuclein aggregation: a possible
role as an anti-parkinsonian factor. Neuron. 32:213–223. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park JY and Lansbury PT: Beta-synuclein
inhibits formation of alpha-synuclein protofibrils: a possible
therapeutic strategy against Parkinson's disease. Biochemistry.
42:3696–3700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji HJ, Liu YE, Jia T, et al:
Identification of a breast cancer specific gene, BCSG1, by direct
differential cDNA sequencing. Cancer Res. 57:759–764.
1997.PubMed/NCBI
|
|
6
|
Guo J, Shou C, Meng L, et al: Neuronal
protein synuclein-γ predicts poor clinical outcome in breast
cancer. Int J Cancer. 121:1296–1305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bruening W, Giasson BI, Klein-Szanto AJ,
et al: Synucleins are expressed in the majority of breast and
ovarian carcinomas and in preneoplastic lesions of the ovary.
Cancer. 88:2154–2163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Liu W, Wu Y, et al: Loss of
epigenetic control of synu-clein-gamma gene as a molecular
indicator of metastasis in a wide range of human cancers. Cancer
Res. 65:7635–7643. 2005.PubMed/NCBI
|
|
9
|
Iwaki H, Kageyama S, Isono T, et al:
Diagnostic potential in bladder cancer of a panel of tumor markers
(calreticulin, gamma-synuclein and catechol-o-methyltransferase)
identified by proteomic analysis. Cancer Sci. 95:955–961. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Dong B, Lu AP, et al: Synuclein
gamma predicts poor clinical outcome in colon cancer with normal
levels of carcino-embryonic antigen. BMC Cancer. 10:3592010.
View Article : Google Scholar
|
|
11
|
Guo J, Shou C, Meng L, et al: Neuronal
protein synuclein-γ predicts poor clinical outcome in breast
cancer. Int J Cancer. 121:1296–1305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu K, Quan Z, Weng Z, et al: Expression of
neuronal protein synuclein gamma gene as a novel marker for breast
cancer prognosis. Breast Cancer Res Treat. 101:259–267. 2007.
View Article : Google Scholar
|
|
13
|
Ye Q, Feng B, Peng YF, et al: Expression
of γ-synuclein in colorectal cancer tissues and its role on
colorectal cancer cell line HCT116. World J Gastroenterol.
15:5035–5043. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Surgucheva IG, Sivak JM, Surguchov AP, et
al: Effect of gamma-synuclein overexpression on matrix
metalloproteinases in retinoblastoma Y79 cells. Arch Biochem
Biophys. 410:167–176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan ZZ, Bruening W and Godwin AK:
Involvement of RHO GTPases and ERK in synuclein-gamma enhanced
cancer cell motility. Int J Oncol. 29:289–295. 2006.
|
|
16
|
Seo JH, Rah JC, Choi SH, et al:
Alpha-synuclein regulates neuronal survival via Bcl-2 family
expression and PI3/Akt kinase pathway. FASEB J. 16:1826–1828.
2002.PubMed/NCBI
|
|
17
|
Grunert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie L, Law BK, Chytil AM, Brown KA, Aakre
ME and Moses HL: Activation of the Erk pathway is required for
TGF-β1-induced EMT in vitro. Neoplasia. 6:603–610. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Wang HS, Zhou BH, et al:
Epithelial-mesenchymal transition (EMT) induced by TNF-α requires
AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.
PLoS One. 8:e566642013. View Article : Google Scholar
|
|
20
|
Pan ZZ, Bruening W, Godwin AK, et al:
Gamma-synuclein promotes cancer cell survival and inhibits stress-
and chemotherapy drug-induced apoptosis by modulating MAPK
pathways. J Biol Chem. 277:35050–35060. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu C, Guo J, Qu L, et al: Applications of
novel monoclonal antibodies specific for synuclein-gamma in
evaluating its levels in sera and cancer tissues from colorectal
cancer patients. Cancer Lett. 269:148–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cavallaro U and Christofori G: Cell
adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elizabeth M, Christopher TC and Ian GM:
Zonula occludens-a function in the assembly of tight junctions in
Madin-Darby canine kidney epithelial cells. Mol Biol Cell.
17:1922–1932. 2006. View Article : Google Scholar
|
|
24
|
Surguchov A: Molecular and cellular
biology of synucleins. Int Rev Cell Mol Biol. 270:225–317. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Q, Huang F, Wang XY, et al: Effects of
γ-synuclein on the tumorigenicity and metastasis of colon cancer
SW116 cells in vitro and in vivo. Oncol Rep. 30:2161–2170.
2013.PubMed/NCBI
|
|
26
|
Jiang Y, Liu YE, Lu A, et al: Stimulation
of estrogen receptor signaling by γ-synuclein. Cancer Res.
63:3899–3903. 2003.PubMed/NCBI
|
|
27
|
Chen JY, Jiao L, Xu CL, et al: Neural
protein gamma-synuclein interacting with androgen receptor promotes
human prostate cancer progression. BMC Cancer. 12:5932012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jia T, Liu YE, Liu J and Shi YE:
Stimulation of breast cancer invasion and metastasis by synuclein
γ. Cancer Res. 59:742–747. 1999.PubMed/NCBI
|
|
29
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
